Tag: ABP 501

Eight medicines leap towards EU approval

by Selina McKee | Jan 30, 2017 | News | 0

Eight medicines – including two biosimilars – have taken a giant step towards being approved for the European market having won favour with the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).

Amgen’s Humira biosimilar backed by FDA panel

by Selina McKee | Jul 13, 2016 | News | 0

A US Food and Drug Administration’s advisory committee is supporting the approval of Amgen’s biosimilar of AbbVie’s biologic Humira, the world second best-selling drug.